Rankings
▼
Calendar
IVVD Q4 2022 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena
IVVD
Invivyd, Inc.
$257M
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$48M
Net Income
-$45M
EPS (Diluted)
$-0.37
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$47M
Free Cash Flow
-$49M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$383M
Total Liabilities
$27M
Stockholders' Equity
$356M
Cash & Equivalents
$92M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$48M
-$83M
+42.0%
Net Income
-$45M
-$83M
+46.3%
← FY 2022
All Quarters
Q1 2023 →